Key result
Administration of lorazepam and quetiapine resulted in the complete resolution of isolated catatonia and subsequent psychomotor agitation in a patient with Moyamoya disease.
Why the study?
Psychiatric manifestations of Moyamoya disease are atypical and may be mistaken for primary psychiatric disorders, necessitating a specialized approach to management.
Case Report (n=1)
No
Isolated catatonia can be a rare initial manifestation of Moyamoya disease, highlighting the importance of neurovascular imaging in atypical psychiatric presentations.
May prompt neurovascular imaging in atypical catatonia; leaves open causality and prevalence of Moyamoya association.
Moyamoya disease (MMD) is a rare, idiopathic, and life-threatening cerebrovascular disorder characterized by progressive stenosis and occlusion of the intracranial internal carotid arteries, leading to the formation of abnormal collateral vessels. The incidence of MMD is high in Asian countries but has also been reported in other regions with lower prevalence. Clinically, the disease can manifest with ischemic, hemorrhagic, or epileptic symptoms. Psychiatric manifestations are atypical and may be mistaken for primary psychiatric disorders, necessitating a specialized approach to management. We report a rare clinical case of a patient who was admitted with isolated catatonia and was diagnosed with MMD through neuroimaging. We discuss the possible mechanisms underlying this association, radiological findings, and strategies for managing such an uncommon presentation.
No takes yet. Share an insight, caveat, or question.
Hayani et al. (2025) conducted a case report in Moyamoya disease (n=1). Lorazepam and Quetiapine was evaluated on Resolution of catatonia. Administration of lorazepam and quetiapine resulted in the complete resolution of isolated catatonia and subsequent psychomotor agitation in a patient with Moyamoya disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: